angioedema


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to angioedema: Hereditary angioedema
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.angioedema - recurrent large circumscribed areas of subcutaneous edema; onset is sudden and it disappears within 24 hours; seen mainly in young women, often as an allergic reaction to food or drugs
dropsy, edema, hydrops, oedema - swelling from excessive accumulation of watery fluid in cells, tissues, or serous cavities
Translations

angioedema

n angioedema m
References in periodicals archive ?
Summary: This report on the global Hereditary Angioedema Market analyzes the current and future prospects of the market.
[UKPRwire, Tue Jul 02 2019] This report on the global Hereditary Angioedema Market analyzes the current and future prospects of the market.
M2 PRESSWIRE-June 19, 2019-: Hereditary Angioedema (HAE) Market Spotlight 2019: With Takhzyro Approval, Shire Could Reclaim HAE Prophylaxis Market from CSL Behring
M2 PHARMA-May 29, 2019-KalVista Pharmaceuticals Presents KVD900 Data at C1-Inhibitor Deficiency and Angioedema Workshop
Hereditary angioedema (HAE) due to C1 inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease with deficiency (type I C1-INH-HAE) or dysfunction (type II C1-INH-HAE) of C1 inhibitor (C1-INH) due to mutations in the SERPING1 gene (1-3).
Angioedema is defined as increased permeability and dilatation of the capillaries in the deep dermis or subcutaneous or submucosal tissues leading to localized swelling, often affecting the upper respiratory and gastrointestinal tracts.
In 1882, Quincke first described isolated uvular angioedema. It is a relatively rare presentation of angioedema of the upper airway (1).
Hereditary angioedema (HAE) is a rare disease with an autosomal dominant inheritance and an estimated prevalence of 1:50,000 (1).
BioCryst presented data showing that an oral formulation of BCX7353 was rapidly absorbed and exhibited a long half-life, two important characteristics of desired new acute treatments for hereditary angioedema, or HAE, attacks at the American College of Allergy, Asthma & Immunology, or ACAAI, meeting.
An experimental agent reduced swelling episodes markedly in patients with hereditary angioedema, according to results from a phase 2 randomized, dose-ranging, placebo-controlled trial.
The United States Food and Drug Administration (FDA) has approved Ireland-based Shire's Takhzyro (lanadelumab-flyo) injection as a preventative treatment for hereditary angioedema in patients 12 years of age and older, it was reported yesterday.
THURSDAY, July 26, 2018 (HealthDay News) -- A small-molecule inhibitor of plasma kallikrein, BCX7353, results in a significantly lower rate of hereditary angioedema attacks compared with placebo, according to a study published in the July 26 issue of the New England Journal of Medicine.